-
Not just a hideout: Sahel forests provide base for jihadists
-
Ageless Messi has World Cup scoring record in his sights
-
Africa faces child surgery crisis as key anaesthesia runs out
-
Trump-backed populist wins razor-tight Colombia vote, sparking protests
-
J-Bay: S.Africa's surf mecca missing out on the global tour
-
'Progress', say mediators, after Iran-US talks towards ending war
-
Key points from the first round of Iran-US talks
-
European countries close schools, cancel trains as heatwave set to intensify
-
Crude prices drop, most stocks rise on 'positive' US-Iran talks
-
'Progress', say mediators, after Iran-US talks on ending war
-
Slimy beans: Japanese natto disgusts and delights the world
-
Clark wins despite hecklers but hopes not to be 'heel of the PGA'
-
Cape Verde targeting World Cup knockout rounds after Uruguay draw: coach
-
Father's Day near-miss at US Open brings Burns to tears
-
New coach Rennie names Savea as All Blacks captain
-
Scheffler praises Clark's resolve in gutsy US Open triumph
-
Yamal kickstarts Spain World Cup bid as Cape Verde stun Uruguay
-
Cape Verde fight back for second World Cup draw against Uruguay
-
Mexican fans rally behind Iran as 'our second team' at World Cup
-
Iran-US talks to continue through the night
-
Trump-backed candidate wins razor-tight Colombia presidential election
-
Clark edges Burns by one stroke for second US Open title
-
Iran coach hails 'great achievement' after second World Cup draw
-
Curacao firmly on the map after World Cup heroics
-
Pro-Trump presidential hopeful takes early lead as Colombia counts votes
-
Trump say repairs to begin 'immediately' for Washington pool renovation
-
Yamal off the mark at World Cup in Spain rout as Iran hold Belgium
-
Rune 'not ready' to put a date on tennis return
-
Argentina weaknesses? Austria's World Cup coach can't find any
-
Polls close in Colombia runoff pitting pro-Trump hardliner against leftist
-
A nation divided over Team Melli as Iran faces Belgium
-
McIlroy races for exit after weekend US Open fade
-
Belgium held 0-0 by Iran as Ngoy sent off
-
Mbappe ready for 'special' 100th cap for France at World Cup
-
Watkins ready for England super-sub role at World Cup
-
Yamashita tops Woad in playoff to win Meijer LPGA Classic
-
Clark leads Burns by one as US Open back-nine drama begins
-
Syria president denies wanting to intervene in Lebanon after Trump remarks
-
Timeless Messi eyes World Cup record as Argentina face Austria
-
Saudi critics must be 'realists', says Donis after Spain lesson
-
Brazil must adapt to loss of injured Raphinha at World Cup, says Paqueta
-
Serena Williams given Wimbledon singles wildcard
-
'Absurd' to doubt Spain, says De la Fuente after Saudi Arabia rout
-
Iranians walk out of talks venue after Trump threat
-
Iraq's Arnold promises to have a go against France at World Cup
-
'Toy Story 5' rakes in $160 mn in year's best opening weekend
-
Legendary Cuban spy chief Ramiro Valdes dies at 94
-
Yamal off the mark at World Cup as Spain thrash Saudi Arabia
-
Clark and Scheffler begin final-round drama at US Open
-
Yamal off mark at World Cup as Spain thrash Saudi
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
O.Bulka--BTB